Evaluation of macrophage electrophoretic mobility (MEM) (Ambrose, I965) . This method of cell electrophoresis was first applied in experimental immunology by Sunderam, Phondke, and Ambrose (I967) , who showed that the electrophoretic migration of peritoneal macrophages from a guinea-pig previously immunized with a given antigen is slowed when that antigen is present in the incubation medium. Similarly, the speed of migration of blood lymphocytes in an electrical field is slower in the presence of the antigen to which they are sensitized (Bert, Di Cossano, and Pecco, I969).
One of the techniques currently available for the in vitro diagnosis of cellular immunity is the macrophage migration inhibition test introduced by David, Al-Askari, Lawrence, and Thomas (I964). When guinea-pig peritoneal macrophages (or, as the test has been modified recently, human blood leucocytes) are put into a capillary tube mounted horizontally in a chamber containing a culture medium they migrate in the space of I2 to 24 hours to form a mushroom, the area of which can be measured. If sensitized T-lymphocytes are present among the macrophages and the antigen to which these lymphocytes are sensitized in vivo are present in the ambient fluid the mushroom formed by the macrophage (or the leucocyte) migration is much reduced, and the reduction in the area (expressed as percentage migration inhibition) is a measure of the degree of cellular immunity or delayed hypersensitivity. This slowing or inhibition of migration is the result of the interaction of the antigen with sensitized, thymus-derived T-lymphocytes, which in turn produce a migration inhibition factor (MIF): this acts on the macrophages and blood leucocytes to alter their metabolism in such a way that their locomotion is slowed down. Field and Caspary (1970) reported an in vitro test for cancer in which lymphocytes from patients with malignant disease can be stimulated by a basic protein derived from human brain, commonly known as encephalitogenic factor (EF), to release a macrophage-slowing factor (MSF) which appears to reduce the electrophoretic mobility of guinea-pig macrophages. This technique, which is now called the macrophage electrophoretic mobility (MEM) test, is in fact a macrophage migration inhibition test performed in an electrical field. The macrophage slowing factor (MSF) is possibly related to the migration inhibition factor (MIF). The technique, however, differs in one important respect: whereas in the migration inhibition test the active movement of the macrophages is altered in the MEM test it is their passive movement in an electrical field which is grossly affected.
The validity of this new in vitro blood test for cancer has been independently confirmed by Pritchard, Moore, Sutherland, and Joslin (1972) . Attempts to confirm these findings by Londonbased workers, however, have been unsuccessful (Dale and Mongar, 1974; Forrester, I974, personal communication). Since ocular melanomas are antigenic (Rahi, 1971 (Rahi, , 1973 Wong and Oskvig, 1974; Federman, Lewis, Clark, Egerer, and Sarin, I974) Tc gives the percentage slowing of the macrophage and the measure of lymphocyte sensitization to the antigen.
The encephalitogenic factor used was prepared from fresh human brain white matter essentially by the method of Palmer and Dawson (I969) .
The working of the instrument and the reliability of the recordings were tested using human red blood cells in phosphate buffer saline (pH 7 2). Because of frequent vibrations in the room, owing either to moving traffic or to people working next door, and also owing to microleaks (often not easily detectable) in the electrophoresis chamber, it took us about six months before the mobility of red blood cells could be accurately measured and considered reproducible. A glass disc which provides an air-tight seal between the electrode compartment and the counting chamber was found to be the main cause of drift and faulty movement of the cells. This was later replaced by a plastic disc with a ring washer, designed in our own workshop after discussions with Dr Forrester of the Chester Beatty Cancer Research Institute, London.
After standardization of the instrument with human red blood cells normal guinea-pig macrophages were tested for reproducibility. It was soon realized that selection of macrophages for their size would be the most important criterion for studying mobility differences. Although only macrophages of about I6 [tm were studied, we found that macrophages from different animals behaved differently and only occasionally could any correlation be achieved. We struggled with this particular variability for another six months with little success, and we now consider it to be one of the major drawbacks of the test. The originators of the test admit that guinea-pigs are susceptible to many diseases that tend to modify the electrophoretic mobility of macrophages and they recommend that investigators should breed their own guinea-pigs and handle them with the strictest antiseptic precautions. In their view, healthiness of the guinea-pigs is of primary importance (Field, 1973) .
Guinea-pigs were systemically immunized against PPD and were used to provide both sensitized lymphocytes and peritoneal macrophages for mobility testing.
Another group of guinea-pigs were systemically immunized with crude retinal (photoreceptor) homogenate in Freund's complete adjuvant. At the end of the immunization schedule, which consisted of four intramuscular injections each of visual cell suspension Evaluation of macrophage electrophoretic mobility 59I from one homologous retina, the animals were injected intraperitoneally with 20 ml of liquid paraffin and the macrophages so harvested were used for MEM study.
The direct effect of human basic myelin protein (that is, the encephalitogenic factor) on the mobility of guinea-pig macrophages was measured in a separate study.
Blood lymphocytes from four histologically proved cases of choroidal melanoma and six strongly suspected cases of uveal melanoma (one of which was later proved to be a malignant lesion) were included in the study. Peripheral lymphocytes from io patients with nonneoplastic eye diseases such as uveitis, scleritis, posttraumatic endophthalmitis, and giant cell arteritis and from two healthy laboratory workers were used as control.
Results
Even when only macrophages of a particular size were studied the average migration time varied from one animal to another and especially from one batch to another. The migration time over a distance of 32 ,tm varied from as low as I7 s to as high as 6-8 s.
One group of animals immunized with PPD showed I3 per cent slowing of the macrophages when these cells were treated with supernate containing macrophage slowing factor (MSF) ( Table I ). The other group of animals, on the contrary, did not show any slowing-indeed, an increase in speed was noted (Table II) .
Lymphocytes obtained from animals immunized against retinal antigen produced a slowing factor at I0 mg concentration per sample which retarded the mobility of the macrophages by I4 per cent. At higher antigen concentration the effect was less pronounced (Table III) . The human encephalitogenic factor (EF) acting directly on guinea-pig macrophages had a variable effect on the general mobility. Although the slowing was generally below 3 per cent, on some occasions a slowing up to 7 per cent was noted (Table IV) .
Lymphocytes from melanoma patients treated with I00 jig of EF seemed to release a factor which slowed the macrophage mobility by 7 per cent as opposed to 3 per cent in the control tube (Table V) (Jenssen, Jenssen, Kohler, and Friemel, 1976 
